Charles Milrod, MD
Charles Milrod, MD

@CharlesMilrod

8 Tweets 5 reads Mar 24, 2023
Picture this:
A patient with breast cancer is found unconscious at home, and you find this πŸ‘‡ on your evaluation.
What’s going on? πŸ€”
🧡 1/6
To guide our thoughts, let’s start with 3 thrombotic microangiopathy (TMA) facts-
1) TMA is a syndrome of RBC hemolysis via direct trauma from thrombi in small vessels
2) πŸ”‘ Cancer-associated TMA has a one-month mortality of ~50% 🀯
🧡 2/6
Cancer-associated TMA happens when cancer cells circulate in the blood and lead to…
1️⃣ fibrin deposition
and 2️⃣ small vessel occlusion
Imagine RBCs being sheared as they squeeze through these fibrin bandsπŸ‘‡ 🀯
🧡 3/6
With this high mortality in mind…
Which therapy ⬆️ overall survival for cancer-associated TMA? πŸ€”
🧡 4/6
πŸ†˜ There is ⬇️ survival with plasma exchange or transfusion alone
because 1️⃣ the effect is transient
and 2️⃣ it doesn’t address the underlying driver
πŸ”‘ In this retrospective studyπŸ‘‡ cancer-directed therapy increased survival
🧡 5/6
Key takeaways:
πŸ”‘ Cancer can directly cause a thrombotic microangiopathy (TMA)
🀯 Cancer-associated TMA has a 1-month mortality of ~50%
πŸ”‘ Cancer-directed therapy ⬆️ overall survival
🧡 6/end
Thanks for sticking around- I hope you learned something new!
Thank you @myelomatic for the review πŸ™

Loading suggestions...